Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Knowledge, attitude, and practice of adverse drug reaction monitoring and reporting among nurses and interns in a tertiary care teaching hospital – A questionnaire-based study

Divyasri Koneru, Kumar Pojala, Rajitha Maddala.




Abstract

Background: Pharmacovigilance program was introduced to improve patient safety. Adverse drug reaction (ADR) monitoring and reporting is the key component of this program.

Aims and Objectives: Objectives of the study were (1) to assess the knowledge, attitude, and practice of ADR monitoring and reporting among nurses and (2) to assess the knowledge, attitude, and practice of ADR monitoring and reporting among interns.

Materials and Methods: This was a qualitative, cross-sectional, and questionnaire-based study. A questionnaire containing 40 questions (including the subquestions) was given to study participants. This questionnaire comprises knowledge, attitude, and practice sections.

Results: Data were analyzed in terms of percentages (%) using Excel. 99% of the interns were aware that there is an ADR reporting system in India but only 33% were reported. 93% of the nurses aware of the existence of the ADR reporting system in India, but knowledge about other aspects of pharmacovigilance was poor (

Key words: Pharmacovigilance; Adverse Drug Reaction; Interns; Nurses






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.